Latest period
$207.62B
YoY change
-2.5%
5Y CAGR
+6.2%
Peak year (2023)
$226.50B
Latest annual
$208.16B
Total Assets history chart for Pfizer (PFE) from 1985 to 2025
Latest: $208.16B
Total Assets growth chart for Pfizer (PFE) from 1985 to 2025
Latest: -2.5%
Total Assets history table for Pfizer (PFE) from 1985 to 2025
| 2025 | $208.16B | -2.5% | −$5.24B | ||
| 2024 | $213.40B | -5.8% | −$13.11B | ||
| 2023 | $226.50B | +14.9% | +$29.30B | ||
| 2022 | $197.21B | +8.7% | +$15.73B | ||
| 2021 | $181.48B | +17.7% | +$27.25B | ||
| 2020 | $154.23B | -7.9% | −$13.26B | ||
| 2019 | $167.49B | +5.1% | +$8.07B | ||
| 2018 | $159.42B | -7.2% | −$12.38B | ||
| 2017 | $171.80B | +0.1% | +$182.00M | ||
| 2016 | $171.62B | +2.5% | +$4.16B | ||
| 2015 | $167.46B | -1.1% | −$1.81B | ||
| 2014 | $169.27B | -1.6% | −$2.83B | ||
| 2013 | $172.10B | -7.4% | −$13.70B | ||
| 2012 | $185.80B | -1.2% | −$2.20B | ||
| 2011 | $188.00B | -3.6% | −$7.01B | ||
| 2010 | $195.01B | -8.4% | −$17.93B | ||
| 2009 | $212.95B | +91.6% | +$101.80B | ||
| 2008 | $111.15B | -3.6% | −$4.12B | ||
| 2007 | $115.27B | +0.4% | +$431.00M | ||
| 2006 | $114.84B | -2.3% | −$2.73B | ||
| 2005 | $117.56B | -4.9% | −$6.12B | ||
| 2004 | $123.68B | +5.9% | +$6.91B | ||
| 2003 | $116.78B | +151.9% | +$70.42B | ||
| 2002 | $46.36B | +18.4% | +$7.20B | ||
| 2001 | $39.15B | +16.8% | +$5.64B | ||
| 2000 | $33.51B | +62.9% | +$12.94B | ||
| 1999 | $20.57B | +12.4% | +$2.27B | ||
| 1998 | $18.30B | +19.3% | +$2.97B | ||
| 1997 | $15.34B | +4.6% | +$669.00M | ||
| 1996 | $14.67B | +15.2% | +$1.94B | ||
| 1995 | $12.73B | +14.7% | +$1.63B | ||
| 1994 | $11.10B | +18.9% | +$1.77B | ||
| 1993 | $9.33B | -2.7% | −$259.20M | ||
| 1992 | $9.59B | -0.5% | −$44.50M | ||
| 1991 | $9.63B | +6.4% | +$582.60M | ||
| 1990 | $9.05B | +8.7% | +$727.20M | ||
| 1989 | $8.32B | +9.0% | +$687.20M | ||
| 1988 | $7.64B | +10.3% | +$715.00M | ||
| 1987 | $6.92B | +34.1% | +$1.76B | ||
| 1986 | $5.16B | +15.7% | +$700.80M | ||
| 1985 | $4.46B | — | — |
- 2025$208.16B-2.5%
- 2024$213.40B-5.8%
- 2023$226.50B+14.9%
- 2022$197.21B+8.7%
- 2021$181.48B+17.7%
- 2020$154.23B-7.9%
- 2019$167.49B+5.1%
- 2018$159.42B-7.2%
- 2017$171.80B+0.1%
- 2016$171.62B+2.5%
- 2015$167.46B-1.1%
- 2014$169.27B-1.6%
- 2013$172.10B-7.4%
- 2012$185.80B-1.2%
- 2011$188.00B-3.6%
- 2010$195.01B-8.4%
- 2009$212.95B+91.6%
- 2008$111.15B-3.6%
- 2007$115.27B+0.4%
- 2006$114.84B-2.3%
- 2005$117.56B-4.9%
- 2004$123.68B+5.9%
- 2003$116.78B+151.9%
- 2002$46.36B+18.4%
- 2001$39.15B+16.8%
- 2000$33.51B+62.9%
- 1999$20.57B+12.4%
- 1998$18.30B+19.3%
- 1997$15.34B+4.6%
- 1996$14.67B+15.2%
- 1995$12.73B+14.7%
- 1994$11.10B+18.9%
- 1993$9.33B-2.7%
- 1992$9.59B-0.5%
- 1991$9.63B+6.4%
- 1990$9.05B+8.7%
- 1989$8.32B+9.0%
- 1988$7.64B+10.3%
- 1987$6.92B+34.1%
- 1986$5.16B+15.7%
- 1985$4.46B—
Total Assets values are taken from Pfizer's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported total assets is $207.62B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Pfizer (PFE) reported total assets of $208.16B – edged down 2.5% year-over-year.
Pfizer total assets has grown on net over the period, with a +6.2% compound annual growth rate over 2020–2025 (5 years).
Pfizer total assets peaked at $226.50B in 2023; the latest annual figure is $208.16B in 2025 (8.1% below peak).
The record annual total assets stands at $226.50B, reached in 2023; the historical low of $4.46B was recorded in 1985.
Pfizer Total Assets by Year
Pfizer Total Assets 2025: $208.16B
In 2025, Pfizer reported total assets of $208.16B, edged down 2.5% below 2024.
Pfizer Total Assets 2024: $213.40B
Pfizer total assets in 2024 was $213.40B, declined 5.8% below 2023.
Pfizer Total Assets 2023: $226.50B
2023's total assets for Pfizer came in at $226.50B, grew 14.9% from 2022. This figure represents the highest annual value in the available history.
Pfizer Total Assets 2022: $197.21B
Pfizer posted total assets of $197.21B in 2022, grew 8.7% from 2021.
Pfizer Total Assets 2021: $181.48B
Pfizer total assets in 2021 was $181.48B.
See more financial history for Pfizer (PFE).
Sector peers by Total Assets
Healthcare peers of Pfizer (PFE), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation